Matrixyl (Palmitoyl Pentapeptide) vs Melanotan II
Overview
Matrixyl (Palmitoyl Pentapeptide) and Melanotan II are both cosmetic & skin peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Matrixyl (Palmitoyl Pentapeptide) and Melanotan II across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Matrixyl (Palmitoyl Pentapeptide) | Melanotan II | |
|---|---|---|
| Category | Cosmetic & Skin | Cosmetic & Skin |
| Regulatory status (US) | Research use only | Not approved — Cat. 2 removed (Apr 2026) |
| Typical dosage | Topical application | — |
| Frequency | daily | — |
| Reported benefits | Wrinkle reduction, skin firmness, collagen stimulation, improved skin texture | Skin tanning without UV exposure, increased libido, potential appetite suppression |
| Reported side effects | Very safe for topical use. Rare: mild irritation | Nausea, facial flushing, darkening of moles, potential cardiovascular effects |
Key differences
Primary use. Matrixyl (Palmitoyl Pentapeptide) is categorised under Cosmetic & Skin, while Melanotan II falls under Cosmetic & Skin. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Matrixyl (Palmitoyl Pentapeptide): not FDA-approved; treated as a research compound. Melanotan II: not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it.
Dosing. Matrixyl (Palmitoyl Pentapeptide) is typically dosed at Topical application (daily). Typical dosing for Melanotan II is not catalogued.
Can you stack them?
Some protocols combine peptides, but stacking Matrixyl (Palmitoyl Pentapeptide) and Melanotan II has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Matrixyl (Palmitoyl Pentapeptide) and Melanotan II?
- Matrixyl (Palmitoyl Pentapeptide) and Melanotan II are both cosmetic & skin peptides, but they differ in mechanism, dosing, and regulatory status. Matrixyl (Palmitoyl Pentapeptide) is not FDA-approved; generally classified as a research compound, whereas Melanotan II is not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it.
- What is Matrixyl (Palmitoyl Pentapeptide) used for?
- Palmitoyl pentapeptide-4 (pal-KTTKS), a cosmetic matrikine studied for dermal collagen renewal in a 12-week split-face randomized trial.
- What is Melanotan II used for?
- Tanning, libido.
- Can you take Matrixyl (Palmitoyl Pentapeptide) and Melanotan II together?
- Some users combine peptides within a single protocol, but stacking Matrixyl (Palmitoyl Pentapeptide) and Melanotan II has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Matrixyl (Palmitoyl Pentapeptide) or Melanotan II FDA-approved?
- Matrixyl (Palmitoyl Pentapeptide) is not FDA-approved; generally classified as a research compound. Melanotan II is not FDA-approved; removed from FDA's Category 2 in April 2026, which is not permission to compound it.
Read the full articles
- Matrixyl (Palmitoyl Pentapeptide) — full monograph: mechanism, research, dosing & references
- Melanotan II — full monograph: mechanism, research, dosing & references